233 related articles for article (PubMed ID: 8907274)
21. Prevalence and risk factors of disseminated intravascular coagulation in childhood acute lymphoblastic leukemia.
Songthawee N; Chavananon S; Sripornsawan P; McNeil E; Chotsampancharoen T
Pediatr Res; 2023 Aug; 94(2):588-593. PubMed ID: 36670158
[TBL] [Abstract][Full Text] [Related]
22. Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
Chang H; Kuo MC; Shih LY; Dunn P; Wang PN; Wu JH; Lin TL; Hung YS; Tang TC
Eur J Haematol; 2012 Apr; 88(4):321-8. PubMed ID: 22221178
[TBL] [Abstract][Full Text] [Related]
23. Effect of leukapheresis on blood coagulation in patients with hyperleukocytic acute myeloid leukemia.
Van de Louw A
Transfus Apher Sci; 2017 Apr; 56(2):214-219. PubMed ID: 28041822
[TBL] [Abstract][Full Text] [Related]
24. A study of disseminated intravascular coagulation in acute leukemia reveals markedly elevated D-dimer levels are a sensitive indicator of acute promyelocytic leukemia.
Shahmarvand N; Oak JS; Cascio MJ; Alcasid M; Goodman E; Medeiros BC; Arber DA; Zehnder JL; Ohgami RS
Int J Lab Hematol; 2017 Aug; 39(4):375-383. PubMed ID: 28422420
[TBL] [Abstract][Full Text] [Related]
25. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
26. Hemostatic molecular markers before onset of disseminated intravascular coagulation in leukemic patients.
Wada H; Sakuragawa N; Shiku H
Semin Thromb Hemost; 1998; 24(3):293-7. PubMed ID: 9701463
[TBL] [Abstract][Full Text] [Related]
27. Intravascular coagulation phenomena associated with prevalent fall in fibrinogen and plasminogen during L-asparaginase treatment in leukemic children.
Legnani C; Palareti G; Pession A; Poggi M; Vecchi V; Bianchini B; Coccheri S
Haemostasis; 1988; 18(3):179-86. PubMed ID: 3181817
[TBL] [Abstract][Full Text] [Related]
28. The effect of therapeutic leukapheresis on early complications and outcomes in patients with acute leukemia and hyperleukocytosis: a propensity score-matched study.
Choi MH; Choe YH; Park Y; Nah H; Kim S; Jeong SH; Kim HO
Transfusion; 2018 Jan; 58(1):208-216. PubMed ID: 28960357
[TBL] [Abstract][Full Text] [Related]
29. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
30. Fibrinogen survival and fibrinopeptide A in acute leukemia.
Castaman G; Galloni E; Dri AV; Rodeghiero F
Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
[TBL] [Abstract][Full Text] [Related]
31. Prothrombin fragment 1.2 and modified antithrombin as predictors of disseminated intravascular coagulation and thrombotic risk in thermal injury.
Kowal-Vern A; Walenga JM; Hoppensteadt D; Gamelli RL
J Burn Care Res; 2013; 34(4):459-64. PubMed ID: 23202877
[TBL] [Abstract][Full Text] [Related]
32. Endothelin-1 as an aggravating factor of disseminated intravascular coagulation associated with malignant neoplasms.
Ishibashi M; Ito N; Fujita M; Furue H; Yamaji T
Cancer; 1994 Jan; 73(1):191-5. PubMed ID: 8275424
[TBL] [Abstract][Full Text] [Related]
33. [Metastatic prostate cancer complicated with chronic disseminated intravascular coagulopathy causing acute renal failure, mimicking thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: pathomechanism, differential diagnosis and therapy related to a case].
Deme D; Ragán M; Kalmár K; Kovács L; Varga E; Varga T; Rakonczai E
Magy Onkol; 2010 Dec; 54(4):351-7. PubMed ID: 21163766
[TBL] [Abstract][Full Text] [Related]
34. Disseminated intravascular coagulation in solid tumors: clinical and pathologic study.
Sallah S; Wan JY; Nguyen NP; Hanrahan LR; Sigounas G
Thromb Haemost; 2001 Sep; 86(3):828-33. PubMed ID: 11583315
[TBL] [Abstract][Full Text] [Related]
35. Activation of the coagulation cascade in patients with leptospirosis.
Chierakul W; Tientadakul P; Suputtamongkol Y; Wuthiekanun V; Phimda K; Limpaiboon R; Opartkiattikul N; White NJ; Peacock SJ; Day NP
Clin Infect Dis; 2008 Jan; 46(2):254-60. PubMed ID: 18171258
[TBL] [Abstract][Full Text] [Related]
36. Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.
Yamashita Y; Wada H; Nomura H; Mizuno T; Saito K; Yamada N; Asanuma K; Usui M; Kamimoto Y; Matsumoto T; Ohishi K; Katayama N
Intern Med; 2014; 53(5):413-9. PubMed ID: 24583428
[TBL] [Abstract][Full Text] [Related]
37. Acquired Hypofibrinogenemia Before Asparaginase Exposure During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia: A Report of 2 Cases and Review of the Literature.
Raikar SS; Felker J; Patel KN; Lew G; Sidonio RF
J Pediatr Hematol Oncol; 2018 Oct; 40(7):e470-e472. PubMed ID: 29401102
[TBL] [Abstract][Full Text] [Related]
38. Disseminated intravascular coagulation in a cohort of adult acute leukemia patients: a single center experience.
Alnuaimy SL; Shamoon RP
Blood Coagul Fibrinolysis; 2023 Jan; 34(1):28-32. PubMed ID: 36239573
[TBL] [Abstract][Full Text] [Related]
39. [Patient blood management and transfusion therapy for hemostasis].
Yamamoto K
Rinsho Ketsueki; 2017; 58(10):2141-2149. PubMed ID: 28978859
[TBL] [Abstract][Full Text] [Related]
40. Supportive management strategies for disseminated intravascular coagulation. An international consensus.
Squizzato A; Hunt BJ; Kinasewitz GT; Wada H; Ten Cate H; Thachil J; Levi M; Vicente V; D'Angelo A; Di Nisio M
Thromb Haemost; 2016 May; 115(5):896-904. PubMed ID: 26676927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
